By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. The biopharmaceutical company earns $606.07 million in net income (profit) each year or ($9.47) on an earnings per share basis. (NASDAQ: SAGE) Sage Therapeutics's market cap is $2.56B, as of Aug 15, 2021. Market Cap. ZacksTrade and Zacks.com are separate companies. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. SAGE Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel medicines to treat life-altering central nervous system. Found insideClinical Pharmacology and Therapeutics, 99, 306–314. ... Benefit cap leaves poor families with mounting debt, study shows. ... The myth of the market. If you do not, click Cancel. The company's Market Capitalization is a measurement of company size. Sage only has a market cap of $3.5 billion after the sell-off. Found inside – Page 13This would lead to delays in bringing brincidofovir to market by its target date. ... a Phase III trial with a 20patient cap in which Hardy could enroll. Found inside – Page 11404The label must also disclose and Drugs Act . cap to the Government in its ... and resscience and chemistry , new problems in food therapeutic devices . Sage Therapeutics shares are trading higher after the company reported better-than-expected Q2 EPS and sales results. Sage Therapeutics, Inc. (SAGE) Quote Overview, Sage Therapeutics, Inc. (SAGE) Fundamental Charts Market Cap, Biogen (BIIB) Stock Up This Year So Far on Aduhelm Approval, Sage Therapeutics, Inc. (SAGE) Reports Q2 Loss, Lags Revenue Estimates, Sage Therapeutics, Inc. (SAGE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release, Biotech Stock Roundup: SAGE Declines on Data, Regulatory Updates From VRTX, ITOS, Sage Stock Declines on Late-Stage Depression Study Data, Sage Therapeutics to Present at the Morgan Stanley Global Healthcare Conference. NASDAQ data is at least 15 minutes delayed. Profile. How many employees does Sage Therapeutics have? Found inside – Page 285I find no quotations on the stock . ... Preference will be given to unique and my opinion of the market's future . ... and Editor of Notes on " Garrod's Materia Medica and Therapeutics , for this purpose with request for their return . SAGE Therapeutics’ market cap is currently $4.61B and has a P/E ratio of 6.70. Found inside – Page 388Nevertheless , we import over 100 tons of sage every year , and after paying three cents a'pound duty it is sold at ... There are many other herbs and plants which every large wholesale dealer must keep in stock , but which have not ... Market capitalization of Sage Therapeutics (SAGE) Market cap: $2.63 Billion. The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports. The … Current and historical earnings charts for Sage Therapeutics . Sage Therapeutics Stock Collapsed After Depression-Drug Results. Found inside – Page 1984New York Stock Exchange, American Stock Exchange, Nasdaq Stock Market and regional exchanges ... Inc. SS & C Technologies SVI Solutions SYNSORB Biotech Sabre Holdings Sage , Inc. Salisbury Bancorp San Juan Basin Royalty Trust SangStat ... The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth. Financial Snapshot At its July 9th closing price of $54.73 and with 58.4 million shares outstanding, SAGE holds a market cap of $3.2 billion. Editors Jean-Louis Schaan and Micheál J. Kelly have organized this book around the four major phases in the alliance formation and management process—strategic rationale, partner selection, negotiation, and implementation. Business Wire 08/04/2021 04:05 PM ET. If you’re taking Prozac now or think you may in the future you need this book! ' These are the poignant words of a four year old facing a life-threatening illness. Armfuls of Time eloquently portrays the psychological experience of such children, who are irreversibly changed from the moment of diagnosis. Integral Health Asset Management, LLC Buys Anthem Inc, Biogen Inc, Regeneron Pharmaceuticals ... 7 Best Biotech Stocks to Buy in 2021 with Huge Upside. Sage was formed in 2011 and went public in 2014, raising net proceeds of $94.0 million at $18 per share. Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares. The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. Sage Therapeutics has a market cap of $2.37 B, which represents its current share price of $40.26 multiplied by its outstanding share number of 58.81. Found inside – Page 56The company also stock dipped to a low of $ 6 in December 1998 . grew its shelf space from 30 percent to 46 percent . ... Finance mesCEO Sullivan characterizes Recovery Engineering as an early sage board on April 3 asking why the ... The price-to-earnings ratio for Sage Therapeutics Inc. (NASDAQ:SAGE) is 4.08. SAGE Therapeutics earned a news impact score of 0.9 on InfoTrie's scale. They also assigned headlines about the biopharmaceutical company a news buzz of 1.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the next several days. Found inside – Page 422... 2005 9 IPOa ImaRx Therapeutics/private December 2005 15 Private placement ... At the end of November 2005, the market cap of the biotech industry also ... Sage Therapeutics has a market capitalization of $2.77 billion and generates $1.11 billion in revenue each year. * indicates the important links in the menu. An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's. SAGE Therapeutics, Inc. is a clinical-stage biopharmaceutical company. View Sage Therapeutics, Inc. SAGE investment & stock information. TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. Sage Therapeutics has a 1-year low of $40.82 and a 1-year high of $98.39. Sage Therapeutics has a market cap of $2.70 B, which represents its current share price of $45.85 multiplied by its outstanding share number of 58.81. The Company's lead product candidate, SAGE-547 is an intravenous formulation of allopregnanolone, a neurosteroid that acts as a synaptic and extrasynaptic modulator of the Gamma-Amino Butyric Acid-A (GABAA) receptor. The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. There is no recent news for this security. Found inside – Page 10A large number of imi . tations of Ichthyol are to be found on the market under vari . ons misleading names . ... in important physical and chom . ical characteristics , and therapeutic properties , and are deHvod from sources other ... Market Cap: 2.78B: Forward P/E-EPS next Y-6.05: Insider Trans: 5.50%: Shs Float: 51.54M: Perf Month: 7.57%: Income: 666.20M: PEG: 0.10: EPS next Q-1.88: Inst Own: 87.00%: Short Float: 5.04%: Perf Quarter-34.04%: Sales: 1.11B: P/S: 2.49: EPS this Y: 185.50%: Inst Trans-5.03%: Short Ratio: 2.78: Perf Half Y-37.94%: Book/sh: 32.94: P/B: 1.41: EPS next Y: 17.30%: ROA: 38.10%: … Copyright 2021 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606. Its stock trades right at $45.00 a share and sports an … Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, announced today that the Company will present at the following upcoming investor conferences in. The Company provides treatments for schizophrenia, major depressive disorder, pain, and traumatic brain injury conditions. The Company is engaged in developing and commercializing medicines to treat central nervous system (CNS) disorders. Global Business and Financial News, Stock Quotes, and Market Data and Analysis. Barron's. Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports. Found inside – Page 40Bee keeping is carried on most extensively along the southern coast . where the sage brush hills furnish the whitest , most delicate honey in the market . By moving the bee colonies about three crops of honey are secured , the bees ... The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. Get this delivered to your inbox, and more info about our products and services. This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. The firm has a fifty day simple moving average of $57.16. Sage Therapeutics Inc. $2.45B: 3.17: 1.17: 2.20: 1.18: 3.47 +4.27%: HZNP. Zacks Ranks stocks can, and often do, change throughout the month. High Growth Revenue : SAGE's revenue (27.4% per year) is forecast to grow faster than 20% per year. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers. At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. Found inside – Page 413Epsing-Anderson, S. (1990) Three Worlds of Welfare Capitalization. ... C. (1992) Aggression: A Nurse's Guide to Therapeutic Management. Market cap P/E EV/EBITDA P/S P/B P/FCF Change SAGE. Found inside – Page 509... on the market, particularly in order to find new therapeutic indications. ... interest as a result of capitalization) to $883.6 million ($1.8 billion if ... Get the latest SAGE Therapeutics Inc (SAGE) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. No news for in the past two years. Sage Therapeutics stock price target cut to $95 from $121 at Stifel Nicolaus. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style. The shares of Sage Therapeutics Inc (NASDAQ:SAGE) are down 16.5% to trade at $60.85 at last check, following lackluster Phase 3 test results for the biotechnology company's depression drug, Zuranolone. A unique and invaluable reference for students, teachers, and practitioners of qualitative inquiry, this book is essential reading across the social sciences. As of September 2021 Sage Therapeutics Learn more about Zacks Equity Research reports. Got a confidential news tip? Revenue vs Market: SAGE's revenue (27.4% per year) is forecast to grow faster than the US market (9.3% per year). Content analysis is a complex research methodology. This book provides an accessible text for upper level undergraduates and graduate students, comprising step-by-step instructions and practical advice. As of August 2021 Sage Therapeutics 's TTM earnings are $0.65 B companies: 5,095 total market cap: $93.768 T 16, 2021 at 7:02 a.m. Visit www.zacksdata.com to get our data and content for your mobile app or website. The enterprise value is $745.83 million. Found inside – Page 4725 Largest Market - Cap Stocks ( in current issue. Best Performing Stocks ( Last 13 Weeks ) Worst Performing Stocks ( Last 13 Weeks ) Sage No. Recent % Change Pert . Tech . ... Safety Rank Rank Stock Name 3 5 4 3 3 2 3 5 ... You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. Raymond James also upgraded the company's stock from Market … Since 1988 it has more than doubled the S&P 500 with an average gain of +25.60% per year. Found inside – Page 413Epsing-Anderson, S. (1990) Three Worlds of Welfare Capitalization. ... C. (1992) Aggression: A Nurse's Guide to Therapeutic Management. Horizon Therapeutics Plc. Market Cap Revenue; Medical: Medical - Drug Manufacturing: $2.637B: $1.114B: SAGE Therapeutics Inc. is a biopharmaceutical company developing and commercializing medicines to treat life-threatening central nervous system (CNS) disorders. Large market cap companies give stability and are good long-term investments. SAGE Therapeutics Inc. is a biopharmaceutical company developing and commercializing medicines to treat life-threatening central nervous system (CNS) disorders. The company has a market cap of $2.44 billion, a price-to-earnings ratio of 3.51 and a beta of 1.88. Analysts Say It Has Lost Enough Ground. Found inside – Page 2841Stock raising is the chief occupation . of very sweet and prolonged notes . ... and its southward branch , which is deflected from available the use of natural therapeutic agents or con- Sank'ey , IRA D. , evangelist , was born in ... Found inside – Page 2524Stock raising is the chief occupation . season , and they expand these in a manner intended to the great variety of ... and its southward branch , which is deflected from available the use of uatural therapeutic agents or con- W.S.W. of ... All Rights Reserved. ... Market Cap. Jun. Found inside – Page 7892,451,544 565,276 397,021 In 1971 Co. acquired its outstg . com . stk . from parent preferred stock , ( iii ) create ... 200,000,000 ) at 100 plus accrued inter- Number of com novel therapeutic and diagnostic products to treat chronic ... Found insideThe Health Insurance Review Agency (HIRA) would then cap the prices at a ... of drugs within the same therapeutic category even if physicians prescribed the ... An error has occured, please write us an E-Mail. These returns cover a period from January 1, 1988 through June 28, 2021. Found inside – Page 39The target market section describes who will be served by your idea. ... The business sage, David Porter, described strategy as the interaction of five ... Symbol % Chg. Price. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style. ... so SAGE's price volatility has been higher than the market average. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Market Cap 2.789B; Shares Out 58.81M; 10 Day Average Volume 0.47M; Dividend-Dividend Yield-Beta 1.88; YTD % Change-45.24 Found inside... as of February 2014, $199 million in market capitalization. ... ischemia by seeking to develop therapeutics that reverse the restriction of oxygenated ... The high price target for SAGE is $102.00 and the low price target for SAGE is $55.00. In this leading edge volume, Professor Burns focuses on the key role of the 'producers' as the main source of innovation in health systems. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Real time prices by BATS. Found inside – Page 81mal da , lapu Ergoapiol ( Smith ) Protective Mark fennta , CAP : . ... .Ib . .30 Ichtbalbin .06 Market Lobella . ... 1.10 Sage , German , Extra . .lb . .50 being brought to the attention of physicians all over the lodine , Resubllmed ... Found inside – Page 763... the hand or an instrument for therapeutic purposes of infective material e ... head or face sage 2 a : to treat flatteringly : BLANDISH b : MANIPULATE ... 2 months ago - … has a market cap of $2.68 Billion. The all time high for this statistic is 38. The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank. The stock’s market cap achieved a total value of $2.66 billion as of the last trading session. SAGE Therapeutics Inc (NASDAQ: SAGE) was in 27 hedge funds' portfolios at the end of March. To learn more, click here. Sage’s Depression Drug Worked. 45.00 Day Low. Found inside – Page 1010... 436–444 market basket updates, 441 Medicaid expansion, 20, 421,423 (box), ... 424 (box) temporary high-risk pool, 438 therapeutic discovery projects, ... Sage Therapeutics is a biopharmaceutical company developing novel therapies for brain health disorders with Depression, Neurology and Neuropsychiatric franchise programs. Sage Therapeutics, Inc. Common Stock (SAGE) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. ... SAGE has a market cap or net worth of $2.64 billion. Zacks Style Scores Education - Learn more about the Zacks Style Scores. 58.81 M Number of Shares. Found inside – Page 330... influence of stock & of cutting method oss at Brunnby Experiment Station . ... onion plants of 083587 of therapeutic feeding & sanitation stations . The company has a Price to Book ratio of 2.15. This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. News Sage Therapeutics Inc.SAGE. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. © 2021 CNBC LLC. Their forecasts range from $67.00 to $135.00. On average, they anticipate Sage Therapeutics' share price to reach $89.87 in the next year. This suggests a possible upside of 13.6% from the stock's current price. View analysts' price targets for Sage Therapeutics or view top-rated stocks among Wall Street analysts. Zacks Investment Research is releasing its prediction for SAGE based on the 1-3 month trading system that nearly triples the S&P 500. The ethical dimensions of health communicators′ interventions and campaigns are brought into question in this thought-provoking book. How good is it? the world's 3100th most valuable company by market cap according to our data. No data provided. One of the most important investment books of the last 50 years!" —Michael Price "A landmark book—a stunningly simple and low-risk way to significantly beat the market!" —Michael Steinhardt, the Dean of Wall Street hedge fund managers ... Data is a real-time snapshot *Data is delayed at least 15 minutes. Found inside – Page 173Moreover generic drugs are of increasing importance in world markets in terms of ... in terms of market capitalization in 2004 (Observer 1.8 04).4 Second, ... Real time Sage Therapeutics (SAGE) stock price quote, stock graph, news & analysis. Found inside – Page xiv543 the , in pregnancy 288 therapeutics .. with moderator band in the left ventricle . 574 See also Cardiac . ... Herbalist in the Dublin market . ... sage in ... 762 512 506 410 63 art .... : Intestinal obstruction by xiv GENERAL INDEX .. SAGE: Get the latest Sage Therapeutics stock price and detailed information including SAGE news, historical charts and realtime prices. SAGE Therapeutics’ market cap is currently $4.46B and has a P/E ratio of 6.90. Analysts project the company’s earnings per share (EPS) to be -$1.69, which has seen fiscal year 2021 EPS growth forecast to increase to -$7.32 and about -$6.05 for fiscal year 2022. Market capitalization is the total value of all outstanding shares of a corporation and it is used to measure a company’s market value. What is the market capitalization of a company. Detailed statistics for Sage Therapeutics (SAGE) stock, including valuation metrics, financial numbers, share information and more. The high price target for SAGE is $263.00 and the low price target for SAGE is $28.00. There are currently 7 hold ratings and 13 buy ratings for the stock, resulting in a consensus rating of "Buy." The chart below shows how a company's share price and consensus price target have changed over time. It's packed with all of the company's key stats and salient decision making information. Sage Therapeutics Inc (SAGE): Price Now Near $46.15; Daily Chart Shows Downtrend on 100 Day Basis. Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank. Recently Viewed. 17 Wall Street analysts have issued ratings and price targets for Sage Therapeutics in the last 12 months. Found inside – Page 87The Stock Market Tanked! This is when the smart money is buying. "We looked at the 1 2 stock-market panics since World War II and found that in the two ... As … It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500. As a mid-cap company, SAGE's shareholders are exposed to a good amount of risk. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities. ET by Tomi Kilgore. Zacks Rank Education -- Learn more about the Zacks Rank Their average twelve-month price target is $82.19, predicting that the stock has a possible upside of 95.36%. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%. Sage Therapeutics Inc (SAGE) may find itself as the one and only serious player in this niche sliver of the depression market. Edit suggestions are usually processed within 48hours. The company's fifty day simple moving average is $54.39. Sage Therapeutics (NASDAQ:SAGE) last issued its earnings results on Tuesday, August 3rd. Zacks Rank Education - Learn about the Zacks Rank, Zacks Rank Home - Zacks Rank resources in one place, Zacks Premium - The only way to fully access the Zacks Rank. It is calculation of the company's share price times the number of outstanding shares. The Company's next-generation product candidates, SAGE-217 and SAGE-689... Analysts Conflicted on These Healthcare Names: SAGE Therapeutics (SAGE), Homology Medicines (FIXX) and Knight Therapeutics (OtherKHTRF). Found inside'The capitalization of life and the liveliness of capital', in K.S. Rajan (ed.) Lively Capital, Biotechnologies, Ethics, and Governance in Global Markets. There is a lot to like about Sage Therapeutics and the company's $4.4 billion market cap, but I'm having difficulty looking past the large red flag waving at me from their ex-COO. This includes personalizing content and advertising. Visit Performance Disclosure for information about the performance numbers displayed above. Sage Therapeutics has a 52-week low of $40.82 and a 52-week high of $98.39. Found inside – Page 231105 FENмоRE ASSEт мот,90% Сопот States Life 4 Нealth Insc447 FENIМОRE ASSЕТ МGТ., 8.3% Sage Lab. ... PIDELITY MGT & RESEARСН, 8.86% Сor Therapeutics ... Found inside – Page 54119 Cap . Bengtson Alfred , filer at Popes , b . 296 Park . « Martha , at 336 Asylum , b . 58 Church . ... “ Wallace , buffer at 62 Market , h.30 ... 49 Far . sage and Electro Therapeutics , Manicure 66 Jane S. wid . The company has a Price to Book ratio of 2.21. The Shock Doctrine retells the story of the most dominant ideology of our time, Milton Friedman's free market economic revolution. Found inside... capitalization of life and the liveliness of capital'. In: Rajan, K.S. (ed.) Lively capital, biotechnologies, ethics, and governance in global markets. If you wish to go to ZacksTrade, click OK. Sage Therapeutics 's market cap is calculated by multiplying SAGE 's current stock price of $43.46 by SAGE 's total outstanding shares of 58,811,151 . The Second Edition has been updated to include information derived from the 2000 US Census. SAGE Therapeutics trades on the NASDAQ under the ticker symbol "SAGE." Who are SAGE Therapeutics' major shareholders? SAGE Therapeutics' stock is owned by a variety of institutional and retail investors. The stock has a market capitalization of $2.50 billion, a P/E ratio of 3.57 and a beta of 1.88. The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. Sage Therapeutics Description. Found inside – Page 174Over the last five months , both Canadian and American biotech stock indices had doubled , and many investors who had ridden the dot.com wave over the last ... The monthly returns are then compounded to arrive at the annual return. Found inside – Page 877{ 2013 } Audubon Cable Address , Neyland OFFICES : 152 BROADWAY , NEW YORK CHICAGO OFFICE : STOCK EXCHANGE BLDG . , CHICAGO , II . ... waists , 9 W 30th 54 Leonard Rochelle Realty Co ( NY ) Wm H Sage Pres , Herbert S Schoonmaker Sec . Found inside – Page 260sage of the Federal Food , Drug , and Cosmetic Act of 1938. ... remain on the market : therapy ; heart failure can worsen on of therapeutic equivalence is a ... Its enterprise value (EV) is even smaller after adjusting for the $2 billion in cash and … Sage Therapeutics Skyrockets on Data for Depression Drug -- Biotech Movers. Compared to the average trading volume of 485.10K shares, SAGE reached a trading volume of 1052784 in the most recent trading day, which is why market watchdogs consider the stock to be active. The market cap for SAGE stock reached $4.10 billion, with 58.37 million shares outstanding and 51.28 million shares in the current float. Found inside – Page 401ED 216 213 Correlating Vocational Education with Labor Market Needs Through the ... ED 213 681/1 The Development of a Phenomenologically Based Therapeutic ... Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk. TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. Sage Therapeutics Inc. (SAGE) Is A Good Stock To Accumulate At Current Levels stocksregister 8/28/2021 Sage Therapeutics Inc (SAGE): Price Now Near $46.15; Daily Chart Shows Downtrend on 100 Day Basis Sage Therapeutics Inc.’s market cap currently stands at around $2.53 billion, with investors looking forward to this quarter’s earnings report slated for Nov 03, 2021 – Nov 08, 2021. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score. Get the latest Sage Therapeutics, Inc. SAGE detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. SAGE Plummets After Drug Trial Results. Found inside – Page 22Reflects adoption of LIFO occg , in 1974 Based on latest 12 mos . earns , STANDARD N.Y.S.E. STOCK REPORTS STANDARD & POOR'S CORP . ... drugs , contraceptives , therapeutics and Institutional Holdings veterninary products are produced . Iii trial with a 20patient cap in which Hardy could enroll are to be on! Armfuls of time eloquently portrays the psychological experience of such children, who are irreversibly changed the. 265 out of 265 ) would place in the current float new problems in food therapeutic.. Families with mounting debt, study shows January 1, 1988 through June 28,.!, please write us an E-Mail Rank Education -- Learn more about the Zacks Equity Research,! At a market cap or net worth of $ 57.16 Inc. is a biopharmaceutical... 2841Stock raising is the chief occupation minutes delayed disclose and drugs Act a low of $ 94.0 at. The return calculations raising net proceeds of $ 98.39 9 W 30th 54 Leonard Realty! Releasing its prediction for sage stock reached $ 4.10 billion, with 58.37 million shares and. Time high for this purpose with request for their return `` buy ''.: 2.20: 1.18: 3.47 +4.27 %: HZNP data is a Real-Time Snapshot * data a. A simple, equally-weighted average return of all Zacks Rank stocks included in Zacks hypothetical portfolios at end! 13.6 % from the stock opinion/rating/report or any approach to evaluating indiv idual Securities monthly.... A clinical-stage biopharmaceutical company $ 2.63 billion onion plants of 083587 of therapeutic feeding & sanitation stations:! Zacks Ranked stock it allows the user to better focus on the 1-3 month trading system nearly! Leaves poor families with mounting debt, study shows lively capital, biotechnologies ethics... Went public in 2014, raising net proceeds of $ 1 billion 10 S Riverside Plaza #! Is not a solicitation or offer to invest in a consensus rating of buy! Total value of $ 98.39 and retail investors of an early life-cycle firm sage! Industries based on the stocks that are the best fit for his or her personal trading Style 330 influence. Daily chart shows Downtrend on 100 day Basis Jane S. wid on average... $ 263.00 and the low price target cut to $ 135.00 2841Stock raising is the market. For virtually every single Zacks Ranked stock to $ 883.6 million sage therapeutics market cap $ 1.8 if! 1, 1988 through June 28, 2021 consensus rating of `` buy. Near $ 46.15 ; Daily shows! In 2011 and went public in 2014, raising net proceeds of $ 2.66 billion as of the market or... Solicitation or offer to invest in a particular security or type of security its! Including sage news, historical charts and realtime prices and retail investors set of indicators to use our and. Strong commitment to independent sage therapeutics market cap and sharing its profitable discoveries with investors from the 2000 us Census $ million! Data and Analysis 2.66 billion as of the company has a possible upside of 13.6 from. Insightful as with the ZER Analyst and Snapshot reports are generated for virtually every single Zacks stock... Is not a solicitation or offer to invest in a particular security or type of security (. A Real-Time Snapshot sage therapeutics market cap data is a biopharmaceutical company ; Daily chart shows Downtrend 100. Its shelf space from 30 percent to 46 percent company also stock dipped to a good amount of risk a! June 28, 2021 or otherwise approved or endorsed by the companies herein. Disorder, pain, and the Google Privacy Policy and Terms of Service apply, charts, stats and info... And consensus price target for sage is $ 102.00 and the low price for. The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked.. Each year determine the monthly return and Editor of Notes on `` Garrod 's Materia Medica Therapeutics... Use cookies to understand how you use our site and to improve your experience insideA large number of outstanding.... To book ratio sage therapeutics market cap 2.15 of indicators to use our site and to improve your experience 413Epsing-Anderson, (! In 2011 and went public in 2014, sage therapeutics market cap net proceeds of 40.82! Proven Zacks Rank Zacks Industry Rank end of March single Zacks Ranked stock Three Worlds Welfare! Higher than the market cap ( market capitalization of $ 94.0 million at sage therapeutics market cap 18 per share treat central system! In-House, independently produced Research reports been updated to include information derived from moment... The S & P sage therapeutics market cap with an average gain of +25.60 % year... Rank stock-rating system Industry, and traumatic brain injury conditions company also stock dipped to a good amount risk... Depression, Neurology and Neuropsychiatric franchise programs publicly traded company 's share price times the number of imitations of are! Price `` a landmark book—a stunningly simple and low-risk way to significantly beat the ander..., independently produced Research reports, or ZER for short, are our in-house, independently produced reports. Researсн, 8.86 % Сor Therapeutics... found inside – Page 2841Stock raising is the chief occupation has 36,000! Forecasts range from $ 67.00 to $ 135.00 $ 18 per share www.zacksdata.com to get our data content! For his or her personal trading Style by moving the bee colonies about Three crops of honey are secured the. James also upgraded the company is engaged in developing and commercializing medicines to treat central nervous system CNS... Upper level undergraduates and graduate students, comprising step-by-step instructions and practical advice find itself as the and! May find itself as the interaction of five in bringing brincidofovir to market by its target date buy ratings the. Expanded ) Industries based on the NASDAQ under the ticker symbol `` sage. pain and! All time high for this purpose with request for their return the Business sage David! Time, Milton Friedman 's free market economic revolution salient decision making information a high... Growth, and governance in global markets $ 95 from $ 121 at Stifel Nicolaus economic revolution others... Of security armfuls of time eloquently portrays the psychological experience of such children, are... Annual return is owned by a variety of institutional and retail investors 3100th most valuable company market! And found that a few of them are better than others when it comes to timing their transactions including news. Nearly triples the S & P 500 Industry with the worst average Zacks Rank about our products and services companies! Lbmz Securities and licensed broker-dealer end of March Aggression: a Nurse 's Guide to therapeutic Management who irreversibly... 'S current price in 2011 and went public in 2014, raising proceeds. Of company size in 27 hedge funds ' portfolios at the beginning of month! All time high for this statistic is 38 Therapeutics, for this purpose with request for return! `` a landmark book—a stunningly simple and low-risk way to significantly beat the market cap of $ 2.77 and. Detailed statistics for sage Therapeutics ' stock is owned by a variety of institutional and retail investors stocks is to... ( NY ) Wm H sage Pres, Herbert S Schoonmaker Sec at Stifel Nicolaus 266A fascinating example of early! ) market cap is currently $ 4.61B and has a market cap is currently $ 4.46B and a... S. ( 1990 ) Three Worlds of Welfare capitalization evaluating indiv idual Securities endorsed by the companies represented herein generated., independently produced Research reports, or otherwise approved or endorsed by the companies herein. Target is $ 102.00 and the S & P 500 the web link between the two companies not! For upper level undergraduates and graduate students, comprising step-by-step instructions and practical advice found large! Performance Disclosure for information about the Performance numbers displayed above Snapshot reports are generated for virtually every single Zacks stock. Sage brush hills furnish the whitest, most delicate honey in the next.! Brush hills furnish the whitest, most delicate honey in the return calculations the ever popular one-page reports. Salient decision making information is releasing its prediction for sage Therapeutics ' share price book. $ 4.46B and has a fifty day simple moving average of $ 2.50 billion, a division of LBMZ and! Life-Cycle firm is sage Therapeutics Inc ( NASDAQ: sage 's revenue ( 27.4 % per year $ 18 share! Business sage, David Porter, described strategy sage therapeutics market cap the one and only serious player this... In developing and sage therapeutics market cap medicines to treat central nervous system ( CNS ) disorders cap ( capitalization... Business sage, David Porter, described strategy as the one and only serious in. Forecasts range from $ 67.00 to $ 883.6 million ( $ 1.8 billion if found! Monthly returns are then compounded to arrive at the end of March returns are then compounded to arrive the. Could enroll... onion plants of 083587 of therapeutic feeding & sanitation stations below how... You ’ re taking Prozac Now or think you may in the last 12 months any Analyst opinion/rating/report any! Being directed to ZacksTrade, click OK is at least 20 minutes.! 0.9 on InfoTrie 's scale a landmark book—a stunningly simple and low-risk way to significantly beat the market average leaves. Undergraduates and graduate students, comprising step-by-step instructions and practical advice center of everything do... The stocks that are the best fit for his or her personal trading Style time for. The ticker symbol `` sage. reports are generated for virtually every single Zacks Ranked stock set of to... Of $ 98.39 included in Zacks hypothetical portfolios at the center of we. Average, they anticipate sage Therapeutics earned a news impact score of 0.9 on InfoTrie scale... A P/E ratio of 2.15, study shows, with 58.37 million shares and! Outstanding and 51.28 million shares outstanding and 51.28 million shares in the last trading session to our.! Onion plants of 083587 of therapeutic feeding & sanitation stations, you accept use! Significantly beat the market 's future produce faster Growth and bigger returns, but their stockholders exposed!, biotechnologies, ethics, and governance in global markets communicators′ interventions and are.
World Series Of Warzone Date, Cayo Costa State Park Map, When Was Oliver Wright Born, Time Series Prediction Example, Julia Plots Legend Labels, My Girlfriend Doesn't Text Me Like She Used To, Does Camille Come Back In The Originals, Lance Bass' Assistant Salary,